Skip to content

    Recently Viewed

      Listening...

      Home / Media Center / Press releases / Medical technologies /
      FDA Clears First Blood Glucose Monitoring System To Automatically Send Results Wirelessly Via Bluetooth® Technology to iOS Devices

      FDA Clears First Blood Glucose Monitoring System To Automatically Send Results Wirelessly Via Bluetooth® Technology to iOS Devices

      OneTouch® Verio®Sync Meter With Mobile App Allows Patients To Easily View and Share Blood Sugar Information Using Their iPhone®, iPad® or iPod touch®

      Share Article
      share to

      MILPITAS, Calif., March 4, 2013 /PRNewswire/ -- LifeScan, Inc. announced today that the OneTouch® Verio®Sync Blood Glucose Monitoring System has received clearance from the US Food & Drug Administration (FDA). It is the first meter to automatically send blood glucose results wirelessly via Bluetooth technology to an iPhone, iPad or iPod touch using the OneTouch® Reveal™ mobile app.

      “For so many people, their iPhone, iPad or iPod touch have become a tool of choice to help organize and take charge of their daily lives,” said Ty Lee, Vice President of Marketing, representing the products of LifeScan, Inc. & Animas Corp. “For people with diabetes, the new OneTouch® Verio®Sync System will enable them to use their iOS device to view and share their blood glucose results wirelessly, in much the same way they rely on them in other areas of their lives.”

      Through the OneTouch® Reveal™ mobile app, users will be able to view a variety of personalized information directly on their iPhone, iPad or iPod touch including a 14-day summary of blood sugar test results, simple visuals showing the percentage of test results within target range, and then share that information via email or text with their care providers, family or friends.

      People with diabetes interested in learning more are encouraged to visit www.OneTouch.com where they can sign up to receive email updates on availability and special introductory offers for the OneTouch® Verio®Sync System.

      About the Johnson & Johnson Family of Diabetes Companies
      LifeScan, Inc. is one of the five companies that comprise the Johnson & Johnson Family of Diabetes Companies with the shared vision of “Creating a world without limits for people with diabetes.” Providing advanced products and services, professional and community education, and advocacy and support to people living with diabetes and their families, these companies include: LifeScan, Inc., (www.OneTouch.com) a world leader in blood glucose monitoring; Animas Corporation, (www.Animas.com) maker of innovative insulin delivery systems; Calibra Medical, Inc., developer of a unique, wearable mealtime only insulin patch; Children with Diabetes, Inc., (www.childrenwithdiabetes.com) a community offering support and education for children, adults and their families living with diabetes; and the Johnson & Johnson Diabetes Institute, LLC, (www.JJDI.com) that empowers healthcare professionals with education and training programs to improve the quality of life for people with diabetes.

      iPhone, iPad, and iPod touch are trademarks of Apple Inc., registered in the U.S. and other countries.

      The Bluetooth word mark is a registered trademark owned by Bluetooth SIG, Inc. and any use of such marks by LifeScan, Inc. is under license.

      SOURCE LifeScan, Inc.

      Helen Patrikis or Lara Markenson, Robert Marston Marketing Communications, Inc., +1-212-371-2200

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.